Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Qingsong Zhu

Premium

Insilico Medicine has hired Qingsong Zhu to serve as its chief operating officer. In this role, he will be in charge of the company's operations and drug discovery research initiatives.

Prior to joining the company, Zhu spent seven years as a postdoctoral research fellow in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and has also worked as an independent consultant to apply next-generation sequencing to develop diagnostics and personalized medicine. Zhu holds a bachelors degree in biology from the Beijing Forestry University in Beijing and doctorate in biochemistry from Kansas State University.

Filed under

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.